obesity. 12 The specific mechanisms are unknown and lead to the following questions: Can the clustering of diseases within families be explained by clustering of higher levels of risk factors, or is it due to less readily measurable familial factors that are independent of known risk factor levels? Can risk factor differences in participants with a positive family history be explained by differences in obesity? Does the relation of cardiovascular diseases risk factors with parental history of disease in young adults differ between black and white participants.
The Coronary Artery Risk Development in Young Adults (CARDIA) Study examined black and white young adults from four geographic locations across the United States. This paper presents information on the association between parental history of a See p 1445 disease and risk factors in young adults. It also evaluates whether any observed differences can be explained by an increased prevalence of obesity and examines differences in impact of a positive disease history in the mother, father, or both parents. Further analyses were stratified by race because much less is known about the importance of family history in black young adults.
Methods The CARDLA population consists of 5,115 black and white young adults aged 18-30 years old, who were recruited primarily through telephone contact using community lists. The recruitment and examinations took place in 1985 and 1986 in Birmingham, Alabama; Chicago, Illinois; Minneapolis, Minnesota; and Oakland, California. The number of CARDIA participants was approximately equally distributed across age (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) , race (black, white), sex, and education (high school degree or less, more than high school) groups. A more detailed explanation of CARDIA recruitment has been published elsewhere. 13 
Data Collection
Participants' age, education, race, and sex were self-reported during the recruitment phase and verified during the clinic visit. Subjects were instructed to fast for at least 12 hours before a morning examination. Venous blood was collected using minimal stasis, aliquotted, stored at -70°C, and shipped to central study laboratories. Lipids, lipoproteins, and apolipoproteins were measured by the Northwest Lipid Research Clinics Laboratory, Seattle, Washington. Plasma total cholesterol, high density lipoprotein cholesterol (HDL), and triglycerides levels were determined using enzymic procedure.14-17 Low density lipoprotein cholesterol (LDL) was estimated using the Friedewald equation,18 and apolipoprotein A-I (APO A) and apolipoprotein B (APO B) were analyzed by radioimmunoassay techniques.19,20 Serum insulin was measured using a modification of the immunoassay techniques of Herbert et a121 at the University of Pittsburgh Diabetes Research Center, Pittsburgh, Pennsylvania. Serum glucose was measured by the hexokinase-UV method. Only participants fasting 10 hours or more (n=4,858) were included in analyses using laboratory parameters (lipids, glucose, and insulin). Blood pressure was measured after a 5-minute rest using a Hawksley random zero sphygmomanometer. Three measurements were recorded 1 minute apart and the means of the last two measurements were used in these data analyses. Body weight was measured in light clothing without shoes using a balance beam scale and height was measured using a vertical ruler. Triceps, subscapular, and suprailiac skinfold thicknesses were measured in duplicate using a Harpenden caliper. Participants with skinfolds too large to be accurately measured by the calipers (>50 mm) were assigned a skinfold thickness value of 50 mm. Body mass index was defined as weight (kg) divided by height (m) squared. A more detailed explanation of CARDIA study design and data collection techniques has been published elsewhere. 22 Family history of hypertension, myocardial infarction, diabetes mellitus, stroke, and overweight was obtained from the participant using a self-administered questionnaire.
Statistical Analyses
Data analyses were performed using the SAS Analytic Software Package.23 Descriptive statistics (means, standard deviations, percentiles) were used to define the prevalence of a positive parental history in this young adult cohort. Although the absolute mean levels of risk factors differed across sex groups, the association observed between parental history categories and risk factor levels were similar. Therefore, for simplicity of presentation, sex-adjusted means stratified across race are presented.
Analysis of variance was used to generate risk factor means by parental history of disease adjusted for sex, age, and subscapular skinfold thickness (the body size variable with the strongest overall association with CVD risk factor variables). Two models were used to adjust for potential confounders and to estimate the importance of participant obesity. The first model calculated age-and sex-adjusted mean values of CVD risk factors by parental history of disease. To determine if observed differences in risk factors were attributable to differences in obesity, a second model containing age, sex, and subscapular skinfold thickness was used. Clustering of parental history of two diseases was assessed by comparing the proportion with two diseases observed (actual participant report) to the proportion expected due to chance alone (multiplying the proportion reporting a positive history of each disease). The triglyceride and insulin variables were log transformed in the analyses and used to test for significance; however, geometric means (antilogs) were generated for presentation of adjusted means and variance estimates.
Selection of Variables
To minimize the possibility of spurious associations due to multiple comparisons, the variables used in these analyses were chosen according to apriori hypotheses (i.e., limited to "known" risk factor variables for the specific disease). As a result, blood pressure and body size variables (subscapular skinfold thickness) are reported by parental history of hypertension; lipids, lipoproteins, blood pressure, cigarette smoking, and body size variables are reported by parental history of myocardial infarction (MI); fasting plasma glucose, insulin, triglycerides, HDL, and body size variables are reported by parental history of diabetes mellitus; lipids, lipoproteins, blood pressure, and body size variables are reported by participant-defined parental history of obesity; and blood pressure and body size variables are reported by parental history of stroke. Note that differences observed in the number of participants reporting parental conditions differs between the figures and tables due to exclusion of nonfasting parental history of hypertension. Age-and sex-adjusted subscapular skinfold thickness was 1.0 mm greater in those young adults with a positive parental history of hypertension. The differences in blood pressure levels remained significant even after adjustment for age, sex, and subscapular skinfold thickness (Model 2). To assess the differences associated with reported hypertension in either or both parents, the relation between systolic blood pressure levels adjusted for age and sex was examined in relation to the specific parental history of hypertension ( Figure  1 ). Significantly higher systolic blood pressure levels were detected in the young adult children in the mother only, father only, or both parents hypertensive groups compared to the no parental history group. Although blood pressure levels were highest in participants with two hypertensive parents and lowest in those with no parental history of hypertension, no significant differences were observed between the father only, mother only, and both parents hypertensive groups. Similar relations were observed in white and black participants. Parental History of Myocardial Infarction
The association of parental history of MI with lipids, lipoproteins, and blood pressure levels is presented in Table 4 . Mean-adjusted lipid levels were more adverse in those participants with a positive parental history of MI. The differences observed with MI history for total plasma cholesterol and HDL cholesterol were greater in white participants. Mean plasma cholesterol level was 5.7 mg/dl higher in young white adults with parental MI history and 2.8 mg/dl higher in blacks; HDL cholesterol was 2.4 mg/dl lower in white and 1.3 mg/dl lower (not statistically significant) in black young adults with a positive parental history of MI. These differences in white participants diminished somewhat but were still significant after adjustment for subscapular skinfold thickness. In addition, blood pressure levels were significantly higher in the parental MI group. Systolic blood pressure and diastolic blood pressure levels were higher in both black and white participants with a positive parental MI history. Although a positive trend was observed in all blood pressure and race categories, these differences disappeared after adjustment for subscapular skinfold thickness in black participants and remained significant only for diastolic blood pressure in white participants. Subscapular skinfold thickness was nearly 2.0 mm greater in those young adults with a positive parental history of MI, which contributed in part to the risk differences. No relation was observed between the prevalence of cigarette smoking in young adults and parental history of MI (data not shown). Figure 1 presents age-adjusted total plasma cholesterol levels by parental history of MI. Black and white participants with a history of MI in the father only had the highest levels of plasma cholesterol, while a positive history in the mother only was not significantly different from the negative history group. A positive history of MI in both parents was not associated with a higher plasma cholesterol level than that for a history in the father only, although the number with both parents affected was small. Parental History of Diabetes blood pressure, and body size variables is reported in Table 6 . Participants reporting a positive history had significantly greater body size than those who had a negative parental history of obesity. Subscapular skinfold thickness was 2.9 mm greater in blacks and 2.5 mm greater in whites, with similar increases observed for triceps and suprailiac skinfold thicknesses and body girth measurements. In addition, white participants with a positive history had higher total cholesterol and LDL and lower HDL, while black participants showed nonsignificant changes in lipids and significantly higher blood pressure than those with a negative parental history. These differences diminished or disappeared after adjustment for subscapular skinfold thickness. Figure 2 presents subscapular skinfold thickness across parental obesity history categories. For both black and white participants, significant increases were observed in subscapular skinfold thickness for participants reporting either one or both parents obese. Parental History of Stroke The relation between parental history of stroke and risk factors is shown in Table 7 . An association was observed between parental history of stroke and blood pressure level only in black participants. Among blacks, systolic blood pressure levels were 1.5 mm Hg higher in those individuals with a parental history of stroke. After adjustment for subscapular skinfold thickness this difference (1.1 mm Hg) was not statistically significant. No differences were observed in white participants. A significant relation between systolic blood pressure and type of parental stroke history categories (Figure 2 ) was observed only in black participants with a positive paternal history. It must be noted that only three white participants reported a stroke in both parents, thus diminishing the chances of observing any differences.
Clustering of Parental Disease
To determine if parental history of disease clusters in our population, the prevalence of a concurrent parental history (in either or both parents) of two diseases was assessed (Table 8) . Race-specific expected rates were generated by multiplying the proportion of positive histories in the two categories. This method for calculating the expected proportion with multiple family histories was done using the assumption that parental histories were independent of each other. The observed proportion represents the actual number of participants who reported parental history in both categories. For all diseases, significantly greater numbers of participants reported a parental history of multiple diseases than would be
The association between parental history clusters expected. This increased prevalence ranged from and risk factors in young adults is shown in Table 9 . In 1.2-2.9 times greater than expected and was obgeneral, the more parental conditions reported the served in both white and black participants.
worse the risk factor profile. Mean systolic blood pres- to the data presented above, the strong mediating effect of body size in the relation between family history and risk for disease is shown by the 2.8 unit difference in body mass index in blacks and a 1.7 unit difference in white young adults. Discussion These data show the strong association between cardiovascular disease risk factor levels in young adults and parental history of CVD and obesity. Parental history of disease was associated with abnormal risk factors in both white and black young adults; however, some racial differences were observed. Black participants were more likely to report parental history of hypertension, stroke, and diabetes, and white participants were more likely to report a history of MI and obesity. The racial differences in prevalence of a positive family history are consistent with known differences in adult disease patterns with the exception of obesity. The percentage of participants with no knowledge of disease history was greater for paternal than maternal history. Similar racial differences in both the prevalence of a positive family history and the percent of unknown responses for paternal history have been observed in children. 2 These data provide evidence that the familial clustering of adulthood CVD may be mediated in part by levels of risk factors. A parental history of hypertension was related to both higher blood pressure levels and obesity in these young adults. The increased blood pressure levels were not attributable solely to increased obesity. Other adults with a family history of CHD, in part, is independent of lipids and blood pressure levels. [30] [31] [32] We noted that a parental history of diabetes mellitus was related to increased fasting glucose levels in the participants. Both the prevalence of a positive parental history of diabetes and the association with risk factor levels was greater in black participants, although a substantial portion of the relation observed with fasting insulin and triglyceride levels appeared to be mediated by obesity. Increased fasting and postload glucose levels have been noted previously in persons with a positive family history of diabetes.10'1' The fact that the insulin and triglyceride differences observed with a positive family history are related to obesity reiterates the importance of body size in the prodromal phases of Type II diabetes.
A relation was noted between parental history of obesity and both higher blood pressure levels and a more adverse lipid profile (higher cholesterol, LDL, and lower HDL). Increased body size in participants with a positive family history of obesity has been previously recognized.12 It is of particular interest that differences in blood pressure and lipid values appeared to be primarily mediated by differences in obesity, as they disappeared after adjustment for subscapular skinfold thickness. This association is further corroborated by the fact that the impact of obesity on mortality in adulthood is primarily mediated by abnormal risk factors.33
Of interest were the findings that differences in blood pressure levels were associated with a parental history of stroke only in black participants. Inconsistent results were observed in previous studies assessing a family history of stroke and blood pressure levels, although they were done in smaller studies or in children where the prevalence of parental stroke was extremely low.234 The reason for the lack of a relation in white CARDIA participants is unclear. Although there is a relatively low prevalence of this disease in the parents of both children and young adults due to the late age of onset of strokes in adulthood, this should effect only our power to detect a significant difference. It is possible that there may be a greater extent of misclassification of transient ischemic attacks and strokes in these self-reports, which may dilute any expected true effects when the number of events is small. Another less plausible explanation may be that the specific etiologic mechanisms for a familial predisposition to stroke do not manifest themselves until later life.
Differences were observed in risk factor associations with parental history of disease in both black and white participants. In general, a parental history of disease was associated with an unfavorable risk factor profile in both white and black participants. Interestingly, there were differences in the magnitude of the associations observed between parental history of disease and risk factors across race. Parental history of diabetes and stroke were more highly related to risk factors in black participants, while parental history of myocardial infarction were more highly related to lipids and lipoproteins in white participants.
Parental history of diseases clustered to a much higher degree than expected by chance alone. In 
Limitations
There are a number of limitations of this study. Despite the attempt to obtain a complete assessment of parental history, a substantial number of participants were unaware of their parents' disease status (especially paternal history). Because we classified unknown responses as a negative history, this tendency would bias our results toward the null. Therefore, the differences presented probably underestimate the true risk factor difference attributable to parental history. Another potential drawback of these data is the lack of validation of parental disease by medical record review. Other investigators have detected a relatively good concordance (78%) between a reported family history of MI and medical record validation, suggesting that, despite some imprecision, the reported history gives a reasonable estimate of family history for the diseases we have assessed in this paper.29 Even if some discordance occurs, there is no reason to suspect that this would result in artifactual risk differences, rather, as with any misclassification error, it would be more likely to increase the variability of the parental history measures and lead to an underestimate of the real risk factor differences between these groups. Implications
We have shown that a positive family history of cardiovascular disease in young adults was related to a significantly worse risk factor profile. Overall, similar associations were observed between parental history of disease and risk factor levels in young adulthood in both black and white participants. We have shown that differences were observed in modifiable factors such as obesity, blood pressure, and lipids and lipoprotein levels in young adults with a positive parental history of disease. A reasonable interpretation of this information would be to simply view a positive parental history as a marker for increased risk in children and young adults. These data show the important mediating effect of obesity on risk profiles in young adults. A substantial portion of the adverse risk observed with family history of disease was associated with differences in obesity. Therefore, the differences in risk profiles likely reflect the impact of both environmental and genetic factors and help to identify higher risk young adults in whom close monitoring of risk factors may be warranted. In addition, parental disease would likely be a good motivator to enhance compliance in these individuals for risk factor intervention programs. Our data emphasize that this increased risk for disease in adulthood is due in part to altered risk factor levels which can be modified with early dietary, behavioral, and medical interventions.
